Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021;19(11):1884-1895.
doi: 10.2174/1570159X19666210215122333.

Study of Nutraceuticals and Phytochemicals for the Management of Alzheimer's Disease: A Review

Syed Sayeed Ahmad  1 , Mohammad Khalid  2 , Mohammad A Kamal  3 , Kaiser Younis  4
Affiliations
Review

Study of Nutraceuticals and Phytochemicals for the Management of Alzheimer's Disease: A Review

Syed Sayeed Ahmad et al. Curr Neuropharmacol. 2021.

Abstract

Background: Alzheimer's disease (AD) affects several people worldwide and has devastating impacts on society with a limited number of approaches for its pharmacological treatment. The main causes of AD are not clear yet. However, the formation of senile plaques, neurofibrillary tangles, hyper-phosphorylation of tau protein, and disruption of redox homeostasis may cause AD. These causes have a positive correlation with oxidative stress, producing reactive ions, which are responsible for altering the physiological condition of the body.

Conclusion: Ongoing research recommended the use of phytochemicals as acetylcholinesterase inhibitors to hinder the onset and progression of AD. The natural compound structures, including lignans, flavonoids, tannins, polyphenols, triterpenes, sterols, and alkaloids have anti-inflammatory, antioxidant, and anti-amyloidogenic properties. The purpose of this article is to provide a brief introduction to AD along with the use of natural compounds as new therapeutic approaches for its management.

Keywords: Alzheimer's disease; mechanism of AChE in Alzheimer's disease.; nutraceuticals; nutrients; phytochemicals.

PubMed Disclaimer

Figures

Fig. (1)
Fig. (1)
Mechanism of AChE in Alzheimer disease. (A higher resolution / colour version of this figure is available in the electronic copy of the article).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ahmad S.S., Akhtar S., Danish R.S.M., Kamal M.A., Sayeed U., Khan M.K.A., Siddiqui M.H., Arif J.M. Screening and elucidation of selected natural compounds for anti- Alzheimer’s potential targeting BACE-1 Enzyme: A case computational study. Curr. Comput. Aided. Drug Des. 2017;13(4):311–318. - PubMed
    1. Firoz C.K., Jabir N.R., Khan M.S., Mahmoud M., Shakil S., Damanhouri G.A., Zaidi S.K., Tabrez S., Kamal M.A. An overview on the correlation of neurological disorders with cardiovascular disease. Saudi J. Biol. Sci. 2015;•••:19–23. - PMC - PubMed
    1. Berchtold N.C., Cotman C.W. Evolution in the conceptualization of dementia and Alzheimer’s disease: Greco-Roman period to the 1960s. Neurobiol. Aging. 1998;19(3):173–189. doi: 10.1016/S0197-4580(98)00052-9. - DOI - PubMed
    1. Alzheimer’s Association 2010 Alzheimer’s disease facts and figures. Alzheimers Dement. 2010;6(2):158–194. doi: 10.1016/j.jalz.2010.01.009. - DOI - PubMed
    1. Ahmad S.S., Akhtar S., Jamal Q.M., Rizvi S.M., Kamal M.A., Khan M.K., Siddiqui M.H. Multiple targets for the management of Alzheimer’s Disease. CNS Neurol. Disord. Drug Targets. 2016;15(10):1279–1289. doi: 10.2174/1871527315666161003165855. - DOI - PubMed